Tranzactioneaza Eli Lilly and Company (DE.LLY) - 745 EUR (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 743.3000 EUR
Ask 745.2000 EUR
Minim 742.7000 EUR
Maxim 755.1000 EUR
Pret referinta 752.5000
Volum -
Volum ultima zi 1
Max 52 sapt 885.3000 EUR
Min 52 sapt 518.5000 EUR

Descriere companie

Eli Lilly and Company (www.lilly.com/) is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.

Informatii companie

Nume

Eli Lilly and Company